Author Kügler, Sebastian
-
2009 | Journal Article |
AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice.
Jaworski, T.; Dewachter, I.; Lechat, B.; Croes, S.; Termont, A.; Demedts, D. & Borghgraef, P. et al. (2009)
PloS one, 4(10) art. e7280. DOI: https://doi.org/10.1371/journal.pone.0007280
Details DOI PMID PMC
-
2010 | Journal Article |
Modeling of tau-mediated synaptic and neuronal degeneration in Alzheimer's disease.
Jaworski, T.; Kügler, S. & Van Leuven, F. (2010)
International journal of Alzheimer's disease, 2010. DOI: https://doi.org/10.4061/2010/573138
Details DOI PMID PMC
-
2014 | Journal Article |
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
Janelidze, S.; Nordström, U.; Kügler, S. & Brundin, P. (2014)
The journal of gene medicine, 16(9-10) pp. 300-308. DOI: https://doi.org/10.1002/jgm.2779
Details DOI PMID PMC
-
2016 | Book Chapter
Tissue-Specific Promoters in the CNS
Kügler, S. (2016)
In:Manfredsson, Fredric P. (Ed.), Methods in Molecular Biology Gene Therapy for Neurological Disorders pp. 81-91. New York, NY: Springer New York. DOI: https://doi.org/10.1007/978-1-4939-3271-9_6
Details DOI
-
2018 | Journal Article |
Pathophysiological Consequences of Neuronal α-Synuclein Overexpression: Impacts on Ion Homeostasis, Stress Signaling, Mitochondrial Integrity, and Electrical Activity
Tolö, J.; Taschenberger, G.; Leite, K.; Stahlberg, M. A.; Spehlbrink, G.; Kues, J. & Munari, F. et al. (2018)
Frontiers in Molecular Neuroscience, 11 art. 49. DOI: https://doi.org/10.3389/fnmol.2018.00049
Details DOI
-
2018 | Book Chapter
Pharmacologically Controlled Neurotrophic Factor Gene Therapy for Parkinson’s Disease
Kügler, S. (2018)
In: Gene Therapy in Neurological Disorders pp. 177-193. Elsevier. DOI: https://doi.org/10.1016/B978-0-12-809813-4.00008-9
Details DOI
-
2019 | Book Chapter
MRI-Guided Focused Ultrasound for Targeted Delivery of rAAV to the Brain
Noroozian, Z.; Xhima, K.; Huang, Y.; Kaspar, B. K.; Kügler, S.; Hynynen, K.& Aubert, I. (2019)
In:Castle, Michael J. (Ed.), Adeno-Associated Virus Vectors : Design and Delivery pp. 177-197. New York, NY: Springer New York. DOI: https://doi.org/10.1007/978-1-4939-9139-6_10
Details DOI
-
2019 | Journal Article | Research Paper
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein
Pinho, R.; Paiva, I.; Jercic, K. G.; Fonseca-Ornelas, L.; Gerhardt, E.; Fahlbusch, C. & Garcia-Esparcia, P. et al. (2019)
Human Molecular Genetics, 28(1) pp. 31-50. DOI: https://doi.org/10.1093/hmg/ddy326
Details DOI PMID PMC
-
2019 | Journal Article
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration
Lodygin, D.; Hermann, M.; Schweingruber, N.; Flügel-Koch, C.; Watanabe, T.; Schlosser, C. & Merlini, A. et al. (2019)
Nature, 566(7745) pp. 503-508. DOI: https://doi.org/10.1038/s41586-019-0964-2
Details DOI PMID PMC
-
2019 | Journal Article | Research Paper |
Neuronal Redox-Imbalance in Rett Syndrome Affects Mitochondria as Well as Cytosol, and Is Accompanied by Intensified Mitochondrial O2 Consumption and ROS Release
Can, K.; Menzfeld, C.; Rinne, L.; Rehling, P. ; Kügler, S.; Golubiani, G. & Dudek, J. et al. (2019)
Frontiers in Physiology, 10 art. 479. DOI: https://doi.org/10.3389/fphys.2019.00479
Details DOI PMID PMC
-
2019 | Journal Article |
Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration
Lodygin, D.; Hermann, M.; Schweingruber, N.; Flügel-Koch, C.; Watanabe, T.; Schlosser, C. & Merlini, A. et al. (2019)
Nature, 567(7749) pp. E15-E15. DOI: https://doi.org/10.1038/s41586-019-1047-0
Details DOI PMID PMC
-
2021 | Journal Article
Dementia with Lewy bodies—associated ß-synuclein mutations V70M and P123H cause mutation-specific neuropathological lesions
Psol, M.; Darvas, S. G.; Leite, K.; Mahajani, S. U; Bähr, M. & Kügler, S. (2021)
Human Molecular Genetics, 30(3-4) pp. 247-264. DOI: https://doi.org/10.1093/hmg/ddab036
Details DOI
-
2021 | Journal Article
Optimized pharmacological control over the AAV-Gene-Switch vector for regulable gene therapy
Cheng, S.; van Gaalen, M. M.; Bähr, M. ; Garea-Rodriguez, E. & Kügler, S. (2021)
Molecular Therapy - Methods & Clinical Development, 23 pp. 1-10. DOI: https://doi.org/10.1016/j.omtm.2021.07.007
Details DOI
-
2021 | Journal Article |
Generation and Breeding of EGFP-Transgenic Marmoset Monkeys: Cell Chimerism and Implications for Disease Modeling
Drummer, C.; Vogt, E.-J.; Heistermann, M.; Roshani, B.; Becker, T.; Mätz-Rensing, K. & Kues, W. A. et al. (2021)
Cells, 10(3) pp. 505. DOI: https://doi.org/10.3390/cells10030505
Details DOI
-
2022 | Journal Article | Research Paper
The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease
Garg, P.; Maass, F.; Sundaram, S. M.; Mollenhauer, B.; Mahajani, S.; van Riesen, C. & Kügler, S. et al. (2022)
Molecular and Cellular Neuroscience, 121 art. 103746. DOI: https://doi.org/10.1016/j.mcn.2022.103746
Details DOI PMID PMC
-
2023 | Journal Article |
S-SCAM is essential for synapse formation
Wittenmayer, N.; Petkova-Tuffy, A.; Borgmeyer, M.; Lee, C.; Becker, J.; Böning, A. & Kügler, S. et al. (2023)
Frontiers in Cellular Neuroscience, 17. DOI: https://doi.org/10.3389/fncel.2023.1182493
Details DOI
-
2024 | Journal Article |
Human serum-derived α-synuclein auto-antibodies mediate NMDA receptor-dependent degeneration of CNS neurons
Garg, P.; Würtz, F.; Hobbie, F.; Buttgereit, K.; Leite, K.; Aich, A. & Rehling, P. et al. (2024)
Journal of Neuroinflammation, 21(1) art. 62. DOI: https://doi.org/10.1186/s12974-024-03050-6
Details DOI PMID PMC
-
2024 | Journal Article
Preclinical evaluation of CRISPR-based therapies for Noonan syndrome caused by deep-intronic LZTR1 variants
Knauer, C.; Haltern, H.; Schoger, E.; Kügler, S.; Roos, L.; Zelarayán, L. C. & Hasenfuss, G. et al. (2024)
Molecular Therapy - Nucleic Acids, 35(1) art. 102123. DOI: https://doi.org/10.1016/j.omtn.2024.102123
Details DOI PMID PMC